QureBio Ltd.
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| The Safety and Efficacy of Q-1802 Combined With XELOX in Gastrointestinal Tumors (NCT05964543) | QureBio Ltd. | 2023-06-21 |
| A Study of Q-1802 in Patients With Advanced Solid Tumors (NCT04856150) | QureBio Ltd. | 2021-05-21 |
Track QureBio Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.